Özge Alper

Anti–sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell–adhesion and tumorigenicity in ovarian cancer cells

N. Hacker, D. Salomon, Y. Cho‐Chung, 2000, International journal of cancer.

In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody

M. Shibamori, H. Okada, K. Imagawa, 1992, Japanese journal of cancer research : Gann.

Review of Diabetes Mellitus in Relation to Pancreatic Cancer

Saeyoung Ahn, Özge Alper, Ö. Alper, 2021, Clinical Medical Case Reports and Reviews.

Cytogenetic characterization and H-ras associated transformation of immortalized human mammary epithelial cells

P. Porter, J. McDougall, Krishna Rao, 2006, Cancer Cell International.

Advances in Brief Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line

Z. Szallasi, G. Klus, M. Augustus, 2004 .

Novel anti‐filamin‐A antibody detects a secreted variant of filamin‐A in plasma from patients with breast carcinoma and high‐grade astrocytoma

Koichi Nagasaki, M. Raffeld, L. Harris, 2009, Cancer science.

Protein kinase A-Iα subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway

N. Hacker, Y. Cho‐Chung, Özge Alper, 1999, Oncogene.

Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: Protein kinase A downregulation and cytoplasmic export of CRE-binding proteins

Y. Cho‐Chung, E. Bergmann-Leitner, S. Abrams, 2001, Molecular and Cellular Biochemistry.

Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.

N. Hacker, W. Stetler-Stevenson, E. Bergmann-Leitner, 2001, Journal of the National Cancer Institute.